|
| A.
Global strategies against drug resistance:
roles and perspectives |
| B.
Pneumococcal & Viridans streptococcal
resistance |
| C.
Multiresistant gram-negative bacteria |
| D.
Glycopeptide-resistant enterococci |
| E.
Clinical Microbiology: issues and progress |
| F.
Glycopeptide-resistant gram-positive cocci:
newer options for treatment |
| G.
Antifungal resistance and new antifungal
agents |
| H.
Mycobacterial resistance |
| I.
Viral resistance |
| J.
Pneumococcal vaccines: past, present &
future |
| K.
Newer quinolones for the treatment of
multidrug-resistant pneumococcal pneumonia |
| L.
Staphylococcal resistance |
| M.
Special Lecture |
Past ISAARs
ISAAR 2001
